JNJ-75229414

· Janssen Research & Development, LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JNJ-75229414, covering 2026-04-17 to 2026-04-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study of JNJ-75229414 for Metastatic Castration-resistant Prostate Cancer Participants [Phase 1]